Home > Press > NVE Notified of Grant of Two Patents Related to Laboratory-on-a-Chip Technology
NVE Corporation (Nasdaq:NVEC) announced today that it has been notified by the U.S. Patent and Trademark Office of the expected grant of two patents relating to "laboratory-on-a-chip" technology.
NVE Notified of Grant of Two Patents Related to Laboratory-on-a-Chip Technology
EDEN PRAIRIE, MN | Posted on June 26th, 2007
The company has been notified that patent number 7,235,969, titled "Thin-Film Structure Magnetizable Bead Detector," will issue today and that patent number 7,238,539, titled "Magnetizable Bead Detector," will issue July 3, 2007.
In proposed laboratory-on-a-chip systems, magnetic biological marker nano-beads adhere to an immobilization surface when a targeted biological agent is present. Spintronic biosensors detect magnetic perturbations from the nano-beads to detect and quantify the presence of very low levels of biological or chemical materials.
The grants will bring NVE's U.S. patent total to 44. The company has more than 100 patents worldwide issued, pending, or licensed from others. Links to the new patent and NVE's other U.S. patents can be found at the "About NVE" section of the company's Website ( http://www.nve.com ).
About NVE Corporation
NVE is a leader in the practical commercialization of spintronics, a nanotechnology that many experts believe represents the next generation of microelectronics. NVE licenses its MRAM intellectual property and sells spintronic products, including sensors and couplers, to revolutionize data sensing and transmission.
The NVE Corporation logo is available at
Statements used in this press release that relate to future plans, events, or performance are forward-looking statements that are subject to certain risks and uncertainties including, among others, such factors as uncertainties relating to the grant of patents in the future, risks in the enforcement of our patents, as well as the risk factors listed from time to time in our filings with the SEC, including our Annual Report on Form 10-K and other reports filed with the SEC.
For more information, please click here
Curt A. Reynders
Chief Financial Officer
Copyright © PrimeNewswire
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Nanoparticle technology triples the production of biogas October 23rd, 2014
SUNY Polytechnic Institute Invites the Public to Attend its Popular Statewide 'NANOvember' Series of Outreach and Educational Events October 23rd, 2014
Advancing thin film research with nanostructured AZO: Innovnano’s unique and cost-effective AZO sputtering targets for the production of transparent conducting oxides October 23rd, 2014
Strengthening thin-film bonds with ultrafast data collection October 23rd, 2014
Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014
Nanodevices for clinical diagnostic with potential for the international market: The development is based on optical principles and provides precision and allows saving vital time for the patient October 15th, 2014
Aculon Receives Patent for Application of Enhanced Bonding Layers on Titanium October 9th, 2014
harmaEngine will join Nanobiotix’ pivotal trial for NBTXR3 in Soft Tissue Sarcoma to accelerate its development in Asia-Pacific: PharmaEngine to make milestone payment to Nanobiotix in October 2014 to recognize the value created October 8th, 2014